ArticleRSC advances2026
Surface-confined FRET nanoplatform printed
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The detection of protein biomarkers at low concentrations through fluorescence resonance energy transfer (FRET) remains challenging, as conventional homogeneous assays are often affected by uncontrolled donor-acceptor diffusion, fluorophore quenching, and limited reproducibility. In this work, we propose a two-dimensional solid-supported FRET nanoplatform enabling a surface-confined sensing strategy for the stable and reliable detection of the model biomarker Tumor Necrosis Factor-alpha (TNF-α). The approach combines a nanostructured film of fluorine-doped ZnO (F/ZnO) quantum dots deposited on a glass slide with a high-precision pyro-electrohydrodynamic jet (p-jet) printing technique. Microspots of a high-affinity peptide (P52) were printed onto the F/ZnO layer to control donor-acceptor spacing and optimize fluorophore orientation and density, ensuring efficient FRET and reduced variability between samples. The platform provides stable, reproducible, and concentration-dependent FRET signals in the ng mL
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.